Cargando…
Immune gene therapy of cancer
Cancer gene therapy emerged as a promising treatment modality 3 decades ago. However, the failure of the first gene therapy trials in cancer treatment has decreased its popularity. Likewise, immunotherapy has followed a similar course. While it was a popular and promising treatment with IL-2 and int...
Autor principal: | AKBULUT, Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672354/ https://www.ncbi.nlm.nih.gov/pubmed/32512674 http://dx.doi.org/10.3906/sag-2005-327 |
Ejemplares similares
-
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors
por: Yekedüz, Emre, et al.
Publicado: (2021) -
The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
por: Sonugür, F. Gizem, et al.
Publicado: (2019) -
Evaluation of the 3 mm Thickness Splint Therapy on Temporomandibular Joint Disorders (TMDs)
por: Akbulut, Nihat, et al.
Publicado: (2018) -
Phytocontact Dermatitis due to Mustard Seed Mimicking Burn Injury: Report of a Case
por: Yabanoglu, Hakan, et al.
Publicado: (2012) -
The role of pericytes on the efficacy of bevacizumab in colorectal cancer
por: BESLER, Merve, et al.
Publicado: (2022)